The SHH signalling pathway was found (Fig. 4) to promote glycolysis and breast cancer progression by enhancing the expression of PFKFB3, a key enzyme in the glucose metabolism pathway of breast cancer cells [153]. The gene discussed is PFKFB3; the disease is breast carcinoma.